Estabrook Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Estabrook Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$44
-99.9%
140.0%0.00%
Q3 2022$69,000
+19.0%
140.0%0.00%
Q2 2022$58,000
-28.4%
140.0%0.00%
Q1 2022$81,000
-22.9%
140.0%0.00%
Q4 2021$105,000
-16.7%
140.0%0.00%
Q3 2021$126,000
-25.0%
140.0%0.00%
Q2 2021$168,000
-4.0%
140.0%0.00%
Q1 2021$175,000
-19.7%
140.0%0.00%
Q4 2020$218,000
+65.2%
140.0%0.00%
Q3 2020$132,000
+5.6%
140.0%0.00%
Q2 2020$125,000
+40.4%
140.0%0.00%
Q1 2020$89,000
-23.9%
140.0%0.00%
Q4 2019$117,000140.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders